Bristol Myers Squibb to Present at J.P. Morgan’s 39th Annual Virtual Healthcare Conference

On January 4, 2021 Bristol Myers Squibb (NYSE: BMY) reported that the company will present at J.P. Morgan’s 39th Annual Virtual Healthcare Conference, which will be webcast on Monday, January 11, 2021 (Press release, Bristol-Myers Squibb, JAN 4, 2021, View Source [SID1234573392]). Giovanni Caforio, M.D., Board Chair and Chief Executive Officer will make a formal presentation and answer questions about the company at 7:30 a.m. EST.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors and the general public are invited to listen to a live webcast of the session at View Source Material related to the company’s presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.